Identification of ponatinib and other known kinase inhibitors with potent MEKK2 inhibitory activity.
about
Oncogenic signaling of MEK5-ERK5.The novel kinase inhibitor ponatinib is an effective anti-angiogenic agent against neuroblastoma.Discovery and characterization of an iminocoumarin scaffold as an inhibitor of MEKK2 (MAP3K2).Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations
P2860
Identification of ponatinib and other known kinase inhibitors with potent MEKK2 inhibitory activity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Identification of ponatinib an ...... ent MEKK2 inhibitory activity.
@en
type
label
Identification of ponatinib an ...... ent MEKK2 inhibitory activity.
@en
prefLabel
Identification of ponatinib an ...... ent MEKK2 inhibitory activity.
@en
P2093
P2860
P1476
Identification of ponatinib an ...... ent MEKK2 inhibitory activity.
@en
P2093
Gary L Johnson
John E Scott
Syed Ahmad
P2860
P304
P356
10.1016/J.BBRC.2015.06.029
P577
2015-06-06T00:00:00Z